ABSTRACT
Objective The Philippines has had several COVID-19 infection waves brought about by different strains and variants of SARS-CoV-2. This study aimed to describe COVID-19 outcomes by infection waves using machine learning.
Methods We used a cross-sectional surveillance data review design using the DOH COVID DataDrop data set as of September 24, 2022. We divided the data set into infection wave data sets based on the predominant COVID-19 variant(s) of concern during the identified time intervals: ancestral strain (A0), Alpha/Beta variant (AB), Delta variant (D), and Omicron variant (O). Descriptive statistics and machine learning models were generated from each infection wave data set.
Results Our final data set consisted of 3 896 206 cases and ten attributes including one label attribute. Overall, 98.39% of cases recovered while 1.61% died. The Delta wave reported the most deaths (43.52%), while the Omicron wave reported the least (10.36%). The highest CFR was observed during the ancestral wave (2.49%), while the lowest was seen during the Omicron wave (0.61%). Higher age groups generally had higher CFRs across all infection waves. The A0, AB and D models had up to four levels with two or three splits for each node. The O model had eight levels, with up to 16 splits in some nodes. Of the ten attributes, only age was included in all the decision tree models, while region of residence was included in the O model. F-score and specificity were highest using naïve Bayes in all four data sets. Area under the curve (AUC) was highest in the naïve Bayes models for the A0, AB and D models, while sensitivity was highest in the decision tree models for the A0, AB and O models.
Discussion The ancestral, Alpha/Beta and Delta variants seem to have similar transmission and mortality profiles. The Omicron variant caused lesser deaths despite being more transmissible. Age remained a significant predictor of death regardless of infection wave. We recommend constant timely analysis of available data especially during public health events and emergencies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded in part by a research operational grant from the San Beda University Research and Development Center. All authors did not receive any third party payment or services for any aspect of the study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is an extension of a previous study which utilized a publicly available national surveillance dataset to predict COVID-19 mortality in the Philippines during the early part of the pandemic.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data used in the present study are available online at https://doh.gov.ph/covid19tracker
